Visby Medical Executes Contract Option with BARDA for $25.5M to Develop Rapid Flu-COVID PCR Test Designed for At-Home Use

Investigational diagnostic allows patients to test, speak to a provider, and receive proper treatment in a single visit SAN JOSE, Calif., March 25, 2022 /PRNewswire/ -- Visby Medical™, a leading medical diagnostic company, today announced that it has received an additional $25.5M in...

Click to view original post